Table 2.
Characteristics of the Adult aHUS Cohort (January 1, 2007 to January 1, 2016) | Data |
---|---|
Total number of patients in the cohort | 397 |
Female/male sex ratio | 254/143 |
Age at time of aHUS onset (median yr [range]) | 29.3 (0.1–79.7) |
Child-onset aHUS (%) | 82 (20.6) |
Age when entering the 2007–2016 cohort (median yr [range]) | 34.5 (18–79.7) |
Complement/DGKE abnormality (%) | 260 (65.5) |
CFH | 99 (24.9) |
CFI | 38 (9.6) |
CFB | 2 (0.5) |
C3 | 40 (10.1) |
MCP | 45 (11.3) |
DGKE | 4 (1.0) |
Combined CAP abnormalities | 8 (2.0) |
Anti-CFH antibody | 24 (6.0) |
Patients who reached ESKD before the end of the study period (%) | 224 (56.4) |
Death before the end of the study period (%) | 39 (9.8) |